Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.
23 Huhti 20191min
Use of Neurofilament Light as a Potential Biomarker for Alzheimer's Disease
Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.
22 Huhti 20191min
Continuum Pearls: Behavioral Variant Frontotemporal Dementia
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Fro...
17 Huhti 20191min
The comparative effectiveness of teriflunomide and dimethyl fumarate
Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.
16 Huhti 20191min
Joanna Hellmuth: The Rise of Pseudomedicine for Dementia and Brain Health
Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.
15 Huhti 20191min
65-year-old female with subacute hemiballism
Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism.
11 Huhti 20191min
Continuum Pearls: Hippocampal Sclerosis of Aging
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses hippocampal sclerosis of aging. To learn more, read the article "Hippocampal Sclerosis, Argyrophili...
10 Huhti 20191min
How much periventricular lesions assist in distinguishing migraine with aura from CIS?
Dr. Caterina Lapucci talks about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS.
9 Huhti 20191min
